Protalex Inc (PRTX) financial statements (2022 and earlier)

Company profile

Business Address 131 COLUMBIA TURNPIKE
FLORHAM PARK, NJ 07932
State of Incorp. DE
Fiscal Year End May 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

5/31/2018
5/31/2017
5/31/2016
5/31/2015
5/31/2014
5/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5554874449281,6152,457
Cash and cash equivalents5554874449281,6152,457
Prepaid expense7410756564542
Total current assets:6305955009851,6602,499
Noncurrent Assets
Intangible assets, net (including goodwill)123456
Intangible assets, net (excluding goodwill)123456
Total noncurrent assets:123456
TOTAL ASSETS:6315975039891,6662,506
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities629547607555453734
Accounts payable428489562495413672
Accrued liabilities2015846604063
Debt     4,211
Total current liabilities:6295476075554534,945
Noncurrent Liabilities
Long-term debt and lease obligation75     
Long-term debt, excluding current maturities75     
Liabilities, other than long-term debt1,98920,29916,31912,5249,000 
Due to related parties1,98920,29916,31912,5249,000 
Other undisclosed noncurrent liabilities381,4909334993976,058
Total noncurrent liabilities:2,10221,79017,25213,0239,3976,058
Total liabilities:2,73122,33717,86013,5789,85011,003
Stockholders' equity
Stockholders' equity attributable to parent, including:(2,100)(21,740)(17,356)(12,588)(8,184)(8,497)
Common stock000000
Additional paid in capital102,12277,44677,26672,61865,40353,238
Accumulated deficit(104,222)(99,186)(94,623)(85,207)(73,587) 
Other undisclosed stockholders' equity attributable to parent     (61,735)
Total stockholders' equity:(2,100)(21,740)(17,356)(12,588)(8,184)(8,497)
TOTAL LIABILITIES AND EQUITY:6315975039891,6662,506

Income statement (P&L) ($ in thousands)

5/31/2018
5/31/2017
5/31/2016
5/31/2015
5/31/2014
5/31/2013
Operating expenses(3,776)(3,139)(8,298)(10,775)(10,984)(5,180)
Other undisclosed operating loss(648)(867)(683)(524)(585)(441)
Operating loss:(4,425)(4,006)(8,981)(11,299)(11,569)(5,620)
Nonoperating income
(Investment Income, Nonoperating)
000004
Interest and debt expense(612)(558)(434)(321)(284)(664)
Loss from continuing operations before income taxes:(5,036)(4,564)(9,415)(11,620)(11,852)(6,280)
Income tax expense   (4,648)(4,739) 
Net loss:(5,036)(4,564)(9,415)(16,268)(16,591)(6,280)
Other undisclosed net income attributable to parent   4,6484,739 
Net loss available to common stockholders, diluted:(5,036)(4,564)(9,415)(11,620)(11,852)(6,280)

Comprehensive Income ($ in thousands)

5/31/2018
5/31/2017
5/31/2016
5/31/2015
5/31/2014
5/31/2013
Net loss:(5,036)(4,564)(9,415)(16,268)(16,591)(6,280)
Comprehensive loss, net of tax, attributable to parent:(5,036)(4,564)(9,415)(16,268)(16,591)(6,280)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: